Promise in targeting parasympathetic nerve in COPD

Targeted lung denervation won’t replace drug therapy but instead has the potential to complement drug therapy for patients with moderate to severe COPD. Dr Dirk-Jan Slebos, from the University Medical Centre Groningen, Netherlands, presented the findings of AIRFLOW 2 – a phase 2 randomised controlled study of targeted lung denervation plus tiotropium versus sham bronchoscopy ...